{
    "eid": "2-s2.0-85063423092",
    "title": "Everolimus for the treatment of advanced gastrointestinal or lung nonfunctional neuroendocrine tumors in east asian patients: A subgroup analysis of the RADIANT-4 study",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "East Asian population",
        "Everolimus",
        "mTOR inhibitors",
        "Neuroendocrine tumors",
        "RADIANT-4"
    ],
    "authors": [
        "James C. Yao",
        "Do Youn Oh",
        "Jiaming Qian",
        "Young Suk Park",
        "Fabian Herbst",
        "Antonia Ridolfi",
        "Miguel Izquierdo",
        "Tetsuhide Ito",
        "Liqun Jia",
        "Izumi Komoto",
        "Virote Sriuranpong",
        "Yasuhiro Shimada"
    ],
    "citedby-count": 6,
    "ref-count": 24,
    "ref-list": [
        "Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes",
        "NANETS consensus guidelines for the diagnosis of neuroendocrine tumor",
        "Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: A population-based study",
        "Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States",
        "Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: A nationwide survey analysis",
        "The epidemiology of neuroendocrine tumors in Taiwan: A nation-wide cancer registry-based study",
        "Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: A single-center experience",
        "Neuroendocrine bronchial and thymic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up",
        "Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID Study Group",
        "Lanreotide in metastatic entero-pancreatic neuroendocrine tumors",
        "Current development of mTOR inhibitors as anticancer agents",
        "Everolimus for advanced pancreatic neuroendocrine tumors",
        "Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): A randomised, placebo-controlled, phase 3 study",
        "Everolimus for advanced pancreatic neuroendocrine tumours: A subgroup analysis evaluating Japanese patients in the RADIANT-3 trial",
        "Temsirolimus in the treatment of mantle cell lymphoma: Frequency and management of adverse effects",
        "Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors",
        "Mammalian target of rapamycin (MTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: Predictors, management, and outcomes",
        "Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome",
        "Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus",
        "Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): A randomised, placebo-controlled, phase 3 study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Osaka",
            "@id": "60032227",
            "affilname": "Kansai Electric Power Co., Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032227",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Fukuoka",
            "@id": "60021786",
            "affilname": "Kyushu University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021786",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60021119",
            "affilname": "Seoul National University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021119",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60020857",
            "affilname": "Samsung Medical Center, Sungkyunkwan university",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60018424",
            "affilname": "National Cancer Center Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018424",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rueil-Malmaison",
            "@id": "60013909",
            "affilname": "Novartis Pharma S.A.S.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013909",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60013449",
            "affilname": "China-Japan Friendship Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013449",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Basel",
            "@id": "60009968",
            "affilname": "Novartis International AG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60008706",
            "affilname": "Peking Union Medical College Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008706",
            "affiliation-country": "China"
        }
    ],
    "funding": [
        "Novartis Pharmaceuticals Corporation"
    ]
}